(ITGR) Integer Holdings - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45826H1095
ITGR: Medical Devices, Components, Batteries, Technologies
Integer Holdings Corporation (NYSE:ITGR) is a leading medical device contract development and manufacturing company with operations spanning the United States, Puerto Rico, Costa Rica, and other international locations. The company specializes in producing a diverse array of medical products, including those for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. Its product portfolio also encompasses cardiac rhythm management devices such as implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, and heart failure therapies, as well as neuromodulation products like implantable spinal cord stimulators. Additionally, the company manufactures non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. It further offers rechargeable batteries and chargers, orthopedics, minimally invasive surgery, and general surgery devices, along with portable medical devices such as patient monitoring systems, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Integer Holdings serves multi-national original equipment manufacturers and their subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company, originally known as Greatbatch, Inc., rebranded as Integer Holdings Corporation in July 2016 and has been operational since 1970, with its headquarters located in Plano, Texas.
Integer Holdings Corporation plays a critical role in the medical device industry, providing essential technologies and components that enable the production of life-saving and life-enhancing devices. Its extensive range of products and services underscores its commitment to innovation and quality, making it a trusted partner for leading medical technology companies worldwide. The companys global footprint and diverse product offerings position it as a key player in the healthcare sector, contributing to advancements in patient care and treatment options across various medical specialties.
Based on the provided technical and fundamental data, here is a 3-month forecast for Integer Holdings Corporation (NYSE:ITGR):
Technically, ITGR is trading above its 20-day and 50-day moving averages, indicating potential bullish momentum. However, the stock is below its 200-day moving average, suggesting some longer-term resistance. The Average True Range (ATR) of 4.95 indicates moderate volatility, which could lead to price swings within the forecast period. Support levels may be tested near the SMA 50 (121.17), while resistance could be encountered near the SMA 200 (128.14). Price action may remain range-bound between these levels, with potential for a breakout if momentum increases.
Fundamentally, ITGRs market cap of $4.116 billion reflects its established presence in the medical device industry. The current P/E ratio of 34.70 is elevated, suggesting high valuations relative to earnings. However, the forward P/E of 22.88 indicates market expectations for improved earnings performance. The P/S ratio of 2.40 aligns with industry averages, signaling reasonable valuation relative to sales. The return on equity (RoE) of 7.40% is modest, indicating moderate profitability. Overall, the stocks performance over the next three months will likely be influenced by earnings reports, industry trends, and broader market conditions.
Additional Sources for ITGR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ITGR Stock Overview
Market Cap in USD | 4,306m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2000-09-29 |
ITGR Stock Ratings
Growth Rating | 47.9 |
Fundamental | 33.1 |
Dividend Rating | 0.0 |
Rel. Strength | 9.93 |
Analysts | 4.67/5 |
Fair Price Momentum | 115.74 USD |
Fair Price DCF | 86.11 USD |
ITGR Dividends
No Dividends PaidITGR Growth Ratios
Growth Correlation 3m | -75.7% |
Growth Correlation 12m | 36.7% |
Growth Correlation 5y | 62.4% |
CAGR 5y | 12.02% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | 0.18 |
Alpha | 3.02 |
Beta | 0.609 |
Volatility | 29.14% |
Current Volume | 586.3k |
Average Volume 20d | 728.9k |
As of May 01, 2025, the stock is trading at USD 126.93 with a total of 586,328 shares traded.
Over the past week, the price has changed by +7.59%, over one month by +7.56%, over three months by -11.37% and over the past year by +10.79%.
Neither. Based on ValueRay Fundamental Analyses, Integer Holdings is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 33.08 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ITGR as of May 2025 is 115.74. This means that ITGR is currently overvalued and has a potential downside of -8.82%.
Integer Holdings has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy ITGR.
- Strong Buy: 7
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ITGR Integer Holdings will be worth about 126.6 in May 2026. The stock is currently trading at 126.93. This means that the stock has a potential downside of -0.24%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 147.9 | 16.5% |
Analysts Target Price | 146.9 | 15.7% |
ValueRay Target Price | 126.6 | -0.2% |